Theralase Technologies Inc. V.TLT

Being the first PDT treatment...

[wildbird1]

TLT-Ruvidar is the first PDT treatment to be in a FDA phase11 trial.

When TLT will negotiate a joint venture with a Big Pharma for the first FDA approved PDT treatment,  the selling points for TLT-PDT will be many.

-TLT- PDT can cure patients that Valrubicin, Keytruda, Adstiladrin, CG- Oncology and N803+BCG couldn't cure(FDA approved treatments).
-TLT- PDT cancer treatment has a very high 450 days 37%TR(CR+PR).
-TLT- PDT cancer treatment has no side effects.
-TLT- PDT treatment can cure patients that surgery couldn't cure.
-TLT- PDT cancer treatment can cure patients that Chemotherapy & Radiotherapy couldn't cure.
-TLT- PDT cancer treatment can be adapted to treat many other cancer treatments.
-TLT- PDT treatment can cure patients after only one or two treatments.
- You can also add vaccines to the above.

Note:
Adstiladrin and N803+BCG did get the FDA-BTD approval with 450 days CR% numbers that are lower than TLT-Ruvidar.

For a Big Pharma being the first will implies to always be one step ahead of other future PDT treatments

All the above will add a huge $value to any Big Pharma deals.


I love my TLT shares.

[gojotv!]

I don't think there will be a Big Pharma deal. That would only stifle the cure while Big Pharma tries to figure out how to keep patients in hospital, where Big Pharma makes its money" Ruvidar sends patients home hours after treatment. I'm guessing there will be deals with synergystic firms (if there are any deals at all) that are trying to avoid Big Pharma and keep control (and

[gojotv!]

I notice that the posters "shouting from the rooftops" that they want a Big Pharma deal are relative new to this board. Don't tell me that the sharks aren't circling, and trying to get investors to give up our shares cheap. Maybe they'll even just force them out of our hands, as I've seen so many times before on the Venture exchange, while they reap in the huge profits

[Kingpin68]

Roger has indicated his interest in doing a joint venture deal, but he's not going to give it all away. Just a small piece. The rest Theralase should keep for themselves. Theralase has a lot coming to the table, so not to worry.

[CancerSlayer]

Just need to fatten the piggy bank before any future jv negotiations.   Building reserves will be no less important than obtaining that elusive BTD.  A BTD in hand, however, should help open more friendy financing doors pre-negotiation.  JMO.

[toade1313]

Maybe the 'Musk-kateers' could throw in 20-25 million. 

[lesflics]

The FDA has approved photodynamic therapy to treat: actinic keratosis advanced cutaneous T-cell lymphoma Barrett esophagus basal cell skin cancer esophageal (throat) cancer non-small cell lung cancer squamous cell skin cancer (Stage 0) Photodynamic therapy is also used to relieve symptoms of some cancers, including:  esophageal cancer

[wildbird1]

Thank's lesflics... I should have been more specific in my title. My title should have been, TLT-Ruvidar is the first PDT treatment to treat cancer tumors in a FDA phase11 trial. All the approved treatments in your article are for stage0 cancer. Stage 0 = Abnormal cells are present but have not spread to nearby tissue, also called carcinoma in situs, or CIS, CIS is not cancer, but it could